Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

BACKGROUND: Patients with precursors to multiple myeloma are dichotomised as having monoclonal gammopathy of undetermined significance or smouldering multiple myeloma on the basis of monoclonal protein concentrations or bone marrow plasma cell percentage. Current risk stratifications use laboratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowan, Annie, Ferrari, Federico, Freeman, Samuel S, Redd, Robert, El-Khoury, Habib, Perry, Jacqueline, Patel, Vidhi, Kaur, Priya, Barr, Hadley, Lee, David J, Lightbody, Elizabeth, Downey, Katelyn, Argyelan, David, Theodorakakou, Foteini, Fotiou, Despina, Liacos, Christine Ivy, Kanellias, Nikolaos, Chavda, Selina J, Ainley, Louise, Sandecká, Viera, Pospíšilová, Lenka, Minarik, Jiri, Jungova, Alexandra, Radocha, Jakub, Spicka, Ivan, Nadeem, Omar, Yong, Kwee, Hájek, Roman, Kastritis, Efstathios, Marinac, Catherine R, Dimopoulos, Meletios A, Get, Gad, Trippa, Lorenzo, Ghobrial, Irene M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991855/
https://www.ncbi.nlm.nih.gov/pubmed/36858677
http://dx.doi.org/10.1016/S2352-3026(22)00386-6

Ejemplares similares

Ejemplares similares